{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9108931",
  "DateCompleted": {
    "Year": "1997",
    "Month": "05",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0966-842X",
      "JournalIssue": {
        "Volume": "5",
        "Issue": "2",
        "PubDate": {
          "Year": "1997",
          "Month": "Feb"
        }
      },
      "Title": "Trends in microbiology",
      "ISOAbbreviation": "Trends Microbiol"
    },
    "ArticleTitle": "Problems and prospects of developing effective therapy for common cold viruses.",
    "Pagination": {
      "StartPage": "58",
      "EndPage": "63",
      "MedlinePgn": "58-63"
    },
    "Abstract": {
      "AbstractText": [
        "No effective treatment for common colds has yet been developed. Combination antiviral and anti-inflammatory therapies are the best hope for intervention after the onset of symptoms. Prophylaxis, especially in the form of vaccination, would have a major impact in disease prevention. These approaches offer new avenues for treating populations at risk and are of particular significance to those with asthma or chronic bronchitis."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University Medicine, Southampton General Hospital, UK. slj1@soton.ac.uk"
          }
        ],
        "LastName": "Johnston",
        "ForeName": "S L",
        "Initials": "SL"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Trends Microbiol",
    "NlmUniqueID": "9310916",
    "ISSNLinking": "0966-842X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Adrenal Cortex Hormones"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Inflammatory Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Oligonucleotides, Antisense"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Protease Inhibitors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Vaccines, Synthetic"
    },
    {
      "RegistryNumber": "9008-11-1",
      "NameOfSubstance": "Interferons"
    },
    {
      "RegistryNumber": "Q2WXR1I0PK",
      "NameOfSubstance": "Cromolyn Sodium"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Adrenal Cortex Hormones"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Inflammatory Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Cromolyn Sodium"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Design"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epidemiologic Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "etiology"
      ],
      "DescriptorName": "Inflammation"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Interferons"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Oligonucleotides, Antisense"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Protease Inhibitors"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Vaccines, Synthetic"
    }
  ]
}